As July concludes, momentum in lung cancer research continues to build, marked by FDA decisions, trial progress, and ...

As July concludes, the landscape of hematologic oncology continues to evolve, with notable progress in multiple myeloma, ...

The FDA awarded orphan drug designation to VT3989 for mesothelioma, supporting the experimental cancer treatment’s ...

Clinical trials should be designed to ease travel and financial burdens by using local care, telehealth and remote tools, ...

Jaypirca led to better response rates than Imbruvica in some previously treated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.

Navigating a metastatic castration-resistant prostate cancer (mCRPC) diagnosis while preserving self-identity can feel like ...

When my daughter was diagnosed with breast cancer, writing our truth helped me and others face the harsh realities and ...

Certain treatments may accelerate aging in survivors, but tailored care and healthy habits can help reduce long-term risks, ...

Panelists discuss how patients newly diagnosed with multiple myeloma often face emotional and informational overload, but ...

New insights highlight how prostate cancer is now managed as a chronic disease, with emerging treatments and real-world data offering renewed hope for patients.

Kim White's battle with adrenocortical carcinoma highlights her resilience and determination to live life fully despite her ...

July brought major breast cancer updates, and CURE is sharing the latest, as recent developments underscore how quickly the landscape continues to evolve.